Reaction profile

The FDA adverse-event record for liver fibrosis

38 FDA reports name liver fibrosis, a lower-volume reaction in the CVM extract (VeDDRA 490). Plate stamps and neighbourhood peers follow.

#1879 of 2,481
by report volume (all reactions)
38
reports citing this reaction
71.1%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Liver fibrosis has 38 reports now versus 37 in that prior snapshot: 1 more (2.7%).

Report change
+1
Death-coded reports
+1
Death-coded share
+0.8 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Liver fibrosis changes

FDA AER · VeDDRA plate

Code 490 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 38 reports
  • DEATH-HOT 71.1%
  • LOWER-Q #1879/2481
  • PHOTO-FINISH Clenched jaw
  • SPECIES-DOG Dog · 34
  • DRUG-LEAD Spinosad · 6
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Clenched jaw (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Liver fibrosis

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Clenched jaw · near38Conjunctival reddening · near38Disturbance in attent… · near38Duodenitis · near38Liver fibrosis · this reacti…38Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Liver fibrosis

Liver fibrosis: high death-coded share in the FDA AER plate

Signature read: Liver fibrosis's 71.1% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 38 named reports in the openFDA extract. Death-coded share is upper-third: 27 of 38 reports (71.1% of named reports). Nearest volume peer: Clenched jaw (±0 reports). Lead species Dog (34). Lead co-reported drug Spinosad (6).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 34
Cat 2
Cattle 1
Horse 1

Breeds Most Affected

Shepherd Dog - German 3
Schnauzer - Miniature 2
Beagle 2
Crossbred Canine/dog 2
Terrier - Bull - American Pit 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Spaniel - Springer (unspecified) 1
Pinscher - Miniature 1
Poodle - Standard 1
Cattle (unknown) 1

Associated Drugs

Spinosad 6
Milbemycin Oxime + Spinosad 5
Carprofen 4
Fluralaner 13.64% 12-Week Chew 3
Moxidectin 2
Firocoxib 2
Gabapentin 2
Afoxolaner 2
Doxycycline 2
Fluralaner Chew Tablets 2
Milbemycin Oxime + Praziquantel 2
Ivermectin/Pyrantel Pamoate Chewable 272Mcg/652Mg 1
Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Distemper Virus, St 1
Leptospira Canicola L-15 Strain C-51; Leptospira Grippotyphosa 1550 Lot 10005 St 1
Dinotefuran, Pyriproxyfen 1
Pyrantel Pamoate 1
Bordetella Bronchiseptica, Strain 78-9159, Kb 1
Firocoxib 57 Mg Chewable 1
Monensin Sodium 1
Firocoxib 227 Mg Chewable 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Liver fibrosis (#1879 of 2,481 by report volume); death-coded 71.1%. PlainBreed reaction plate · death-coded share stamp 71.1% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →